Single-dose isotope injection for both preoperative lymphoscintigraphy and intraoperative sentinel lymph node identification in melanoma patients

Melanoma Research

Volumn 7, Issue 6, 1997, Pages 500-506

  Thompson, J F ^a,c   Niewind, P ^b   Uren, R F ^a   Bosch, C M J ^b   Howman Giles, R ^a   Vrouenraets, B C ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Advanced Nuclear Medicine Services   (Australia)

Author keywords

Gamma probe; Lymphatic mapping; Melanoma; Sentinel lymph node

Indexed keywords

ANTIMONY TECHNETIUM SULFIDE TC 99M; DISULFINE BLUE;

ARTICLE; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; INTRADERMAL DRUG ADMINISTRATION; INTRAOPERATIVE PERIOD; LYMPH NODE BIOPSY; LYMPHOSCINTIGRAPHY; MELANOMA; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TECHNIQUE;

ANTIMONY; HUMANS; INTRAOPERATIVE CARE; LYMPH NODES; LYMPHATIC METASTASIS; MELANOMA; PREOPERATIVE CARE; REPRODUCIBILITY OF RESULTS; SCINTILLATION COUNTING; TECHNETIUM COMPOUNDS;

EID: 0031404570     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-199712000-00009     Document Type: Article

References (15)

1. Morton DL, Wen DR, Wbng JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992; 127: 392-399.
2. Norman J, Cruse CW, Espinosa C, et al. Redefinition of cutaneous lymphatic drainage with the use of lymphoscintigraphy for malignant melanoma. Am J Surg 1991; 162: 432-437.
3. Uren RF, Howman-Giles RB, Shaw HM, et al. Lymphoscintigraphy in high risk melanoma of the trunk: predicting draining node groups, denning lymphatic channels and locating the sentinel node. J Nitcl Med 1993; 34:1435-1440.
4. Uren RF, Howman-Giles R, Thompson JF, et al. Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 1994; 4: 395-399.
5. Reinigen D, Cruse CW, Wells K, et al. The orderly progression of melanoma nodal métastases. Ann Stirg 1994; 6: 759-767.
6. Thompson JF, McCarthy WH, Bosch CMJ, et al. Sentinel lymph node status as an indicator 'of the presence of metastatic melanoma in regional lymph nodes. Melanoma Res 1995; 5: 255-260.
7. Alex JC, Weaver DL, Fairbank JT, et al. Gamma-probeguided lymph node localization in malignant melanoma. Surg Oncol 1993; 2: 303-308.
8. Essner R, Foshag L, Morton D. Intraoperative radiolymphoscintigraphy: a useful adjunct to intraoperative lymphatic mapping and selective lymphadenectomy in patients with clinical stage I melanoma. Proceedings of 47tb Cancer Symposium, Society of Surgical Oncology, Houston, March 1994.
9. Van der Veen H, Hoekstra OS, Paul MA, et al. Gamma probe-guided sentinel node biopsy to select patients with melanoma for lymphoscintigraphy. Br J Sttrg 1994; 81: 1769-1770.
10. Kapteijn DAE, Baidjnath Panday RKL, Liem IH, et al. Superiority of "mTc- nanocolloid and intraoperative gamma probe detection over patent blue dye in localizing sentinel lymph nodes in patients with melanoma. EnrJ Nncl Med 1995; 22: 753.
11. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996; 223: 217-224.
12. Nieweg OE, Panday RKL, Muller S, et al. Lymphoscintigraphy, lymphatic mapping and sentinel node biopsy in melanoma patients using a single dose of 99mTccolloid. Abstracts of the European Society of Surgical Oncology, Heidelberg, Germany, 8-11 June, 1994.
13. McCarthy WH, Thompson JF, Uren RF. Invited commentary on article by Krag DN, Meijer SJ, Weaver DL et al. Minimal access surgery for staging malignant melanoma. Arch Surg 1995; 130: 659-660.
14. Bergqvist L, Strand SW, Persson DR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983; 13: 9-19.
15. Nathanson SD, Nelson L, Karvelis KC. Rates of flow of teclinetium 99m-labeled human serum albumin from peripheral injection sites to sentinel lymph nodes. Ann Surg Oncol 1996; 3: 329-335.